Searchable abstracts of presentations at key conferences in endocrinology

ea0090p201 | Reproductive and Developmental Endocrinology | ECE2023

Dopamine Agonist-Resistant Prolactinoma: Case report and literature review

Nutsubidze Teona , Bakhtadze Tekle , Sharadze Tamta , Zhgenti Medea , Jamburia Rezo , Janjgava Shota

The therapy of hyperprolactinemia with dopamine agonists (DAs) is highly effective in the majority of cases (1). However, some patients fail to achieve normal prolactin levels and develop drug resistance towards prescribed medicine. This case study describes a medical history of The Georgian National Institute of Endocrinology patient, with a drug-resistant hyperprolactinemia and inability to conceive. The patientÂ’s MRI scan result has not indicated incidence of pr...

ea0099p154 | Reproductive and Developmental Endocrinology | ECE2024

Aromatase inhibitors and abrupt increase obesity rates among in males during puberty

Jamburia Rezo , Bakhtadze Tekle , Janjgava Shota , Davitashvili Ana , Goletiani Natia , Zhgenti Medea , Giorgadze Elene

Even in the presence of normally circulating androgens, the imbalance between estrogen and androgen in males between the prepubertal and pubertal periods may have an impact on male reproductive function. While there are many variables that affect how each person reaches puberty at different times, boys who are becoming more obese have higher aromatase activity. This enzyme turns testosterone into estradiol permanently, which lowers testosterone levels and raises estrogen level...